The Gottfries-Brane-Steen Scale:: Validity, reliability and application in anti-dementia drug trials

被引:62
作者
Bråne, G
Gottfries, CG
Winblad, B
机构
[1] Sahlgrens Univ Hosp, Inst Clin Neurosci, Dept Psychiat & Neurochem, S-43180 Molndal, Sweden
[2] Huddinge Hosp B, Karolinska Inst, Dept Clin Neurosci Occupat Therapy & Elderly Care, Div Geriatr Med, Huddinge, Sweden
关键词
activities of daily living; Alzheimer's disease; anti-dementia drug trials; behavior; cognition; dementia rating scale; emotional impairment; global function; intellectual impairment; psychogeriatric symptoms; GBS Scale;
D O I
10.1159/000051230
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Neuropsychological investigation using a comprehensive rating scale is important for the diagnosis a nd evaluation of dementia patients over time. Requirements for such a scale include accuracy, reliability, sensitivity of the scale over the disease course and simplicity for clinical use by a wide range of healthcare professionals, Ideally, the scale should also be capable of assessing the impact of pharmacological and non-pharmacological treatment regimens on the management of dementia patients, The Gottfries-Brane-Steen (GBS) Sea re is a comprehensive global assessment tool for evaluating dementia symptoms and is based on a semi-structured interview and observation of the patient, The scale consists of subscales measuring intellectual (12 items), emotional (3 items) and activities of daily living, primarily items of self-care (6 items); as well as 6 items of behavioral and psychological symptoms of dementia, This review describes the reliability, validity and sensitivity of the most recent version of the GBS sea le since its original publication in 1982. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 59 条
[11]   INTEGRITY-PROMOTING CARE OF DEMENTED NURSING-HOME PATIENTS - PSYCHOLOGICAL AND BIOCHEMICAL-CHANGES [J].
BRANE, G ;
KARLSSON, I ;
KIHLGREN, M ;
NORBERG, A .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 1989, 4 (03) :165-172
[13]  
BRANE G, 1989, Alzheimer Disease and Associated Disorders, V3, P148
[14]  
BRANE G, 1992, DIAGNOSIS DEMENTIA P, P205
[15]  
BRANE G, 1989, THESIS GOTEBORG U
[16]  
BRANE G, 1999, 15 INT C ALZH DIS IN
[17]   THE NEUROPSYCHIATRIC INVENTORY - COMPREHENSIVE ASSESSMENT OF PSYCHOPATHOLOGY IN DEMENTIA [J].
CUMMINGS, JL ;
MEGA, M ;
GRAY, K ;
ROSENBERGTHOMPSON, S ;
CARUSI, DA ;
GORNBEIN, J .
NEUROLOGY, 1994, 44 (12) :2308-2314
[18]  
Dehlin O, 1985, Scand J Prim Health Care, V3, P215, DOI 10.3109/02813438509013952
[19]   A DOUBLE-BLIND COMPARISON OF ALAPROCLATE AND PLACEBO IN THE TREATMENT OF PATIENTS WITH SENILE DEMENTIA [J].
DEHLIN, O ;
HEDENRUD, B ;
JANSSON, P ;
NORGARD, J .
ACTA PSYCHIATRICA SCANDINAVICA, 1985, 71 (02) :190-196
[20]  
DENCKER K, 1995, SCAND J CARING SCI, V9, P35